Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Women’s Groups Urge Congress To Review Silicone Implant Panel Meeting

This article was originally published in The Gray Sheet

Executive Summary

The Senate HELP Committee is reviewing a letter from six women's groups requesting a congressional oversight investigation into the recent FDA panel meeting on silicone breast implants

You may also be interested in...



Groups Differ On Impact Of Silicone Breast Implants On Subgroup Populations

Several women's health advocates are concerned about a dearth of data on the effect of silicone breast implants on different patient subgroups, including African American women and breast cancer survivors, though some plastic surgeons suggest that these worries are overblown

Groups Differ On Impact Of Silicone Breast Implants On Subgroup Populations

Several women's health advocates are concerned about a dearth of data on the effect of silicone breast implants on different patient subgroups, including African American women and breast cancer survivors, though some plastic surgeons suggest that these worries are overblown

Bond departs for food group

FDA Director of Science Policy Susan Bond is leaving the agency to become senior vice president of the International Food Information Council, effective Nov. 28. In April, Bond was accused by several women's advocacy groups of pushing for approval of silicone breast implants in an email to then-Commissioner Lester Crawford (1"The Gray Sheet" May 2, 2005, p. 15)...

Related Content

UsernamePublicRestriction

Register

OM017175

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel